Spots Global Cancer Trial Database for doxorubicin induced cardiomyopathy
Every month we try and update this database with for doxorubicin induced cardiomyopathy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients | NCT06092606 | Cancer Heart Failure Arrhythmia Doxorubicin Ind... Doxorubicin Adv... | Control group:D... Trial group: DH... Trial group: DH... | 18 Years - 75 Years | Monyan Pharmaceutical (Shanghai) Co., Ltd. | |
| Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage | NCT05731375 | Doxorubicin Ind... Chemotherapeuti... B-cell Lymphoma T-cell Lymphoma | 31-MRS at 7 Tes... | 18 Years - | UMC Utrecht | |
| A Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer Patients | NCT06092606 | Cancer Heart Failure Arrhythmia Doxorubicin Ind... Doxorubicin Adv... | Control group:D... Trial group: DH... Trial group: DH... | 18 Years - 75 Years | Monyan Pharmaceutical (Shanghai) Co., Ltd. | |
| Evaluation of Myocardial Injury After Anthracycline Chemotherapy in Osteosarcoma Patients Using CMR | NCT04461223 | Cardiotoxicity Osteosarcoma Myocardial Inju... Chemotherapy In... Doxorubicin Ind... | contrast-enhanc... | 8 Years - 50 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity | NCT06427226 | Doxorubicin Ind... Breast Cancer | Dapagliflozin 1... | 18 Years - 65 Years | Tanta University | |
| Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients | NCT03000036 | Breast Cancer F... Doxorubicin Ind... | Doxorubicin Achieva, Philip... Gadoterate Megl... | 18 Years - 75 Years | University of Campinas, Brazil | |
| Doxorubicin-associated Cardiac Remodeling Followed by CMR in Breast Cancer Patients | NCT03000036 | Breast Cancer F... Doxorubicin Ind... | Doxorubicin Achieva, Philip... Gadoterate Megl... | 18 Years - 75 Years | University of Campinas, Brazil | |
| Prevention Using Exercise Rehabilitation to Offset Cardiac Toxicities Induced Via Chemotherapy | NCT02796365 | Doxorubicin Ind... Breast Cancer Gastric Cancer Leukemia | Exercise | 18 Years - 75 Years | Henry Ford Health System | |
| Mitochondrial dysfUnction: a Key Player in Doxorubicin-induced Skeletal and Cardiac muscLE Damage | NCT05731375 | Doxorubicin Ind... Chemotherapeuti... B-cell Lymphoma T-cell Lymphoma | 31-MRS at 7 Tes... | 18 Years - | UMC Utrecht | |
| Evaluation of the Possible Safety and Efficacy of Dapagliflozin in the Prophylaxis of Doxorubicin-Induced Cardiotoxicity | NCT06427226 | Doxorubicin Ind... Breast Cancer | Dapagliflozin 1... | 18 Years - 65 Years | Tanta University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
